Recallab — Illustrated Medical MCQ BankPG About Open the app →

Recallab › Question bank › Orthopaedics › #50271

Chordoma

A 58-year-old man has 18 months of deep sacral pain with recent constipation and perineal numbness. Imaging shows a midline destructive lesion of the sacrum with a large soft tissue mass. Histology shows lobules of cells with vacuolated, bubbly cytoplasm in a myxoid matrix. What is the diagnosis?

Explanation

Key fact
Chordoma is a midline tumour of notochord remnants, and its physaliphorous bubbly cells are diagnostic.

Chordoma. A midline sacral destructive lesion with physaliphorous cells is chordoma and nothing else.

Why

The notochord runs in the midline and regresses, leaving remnants.

Tumours from those remnants therefore arise in the midline.

Half are sacrococcygeal, a third at the clivus, the rest in the vertebral bodies.

Physaliphorous cells - bubbly, vacuolated cytoplasm - are the histological signature.

They are brachyury positive on immunohistochemistry, which confirms notochordal origin.

Growth is slow but relentless, which is why symptoms are present for many months.

Physaliphorous cells in a myxoid matrix

A histological field showing lobules of large cells with abundant clear, bubbly vacuolated cytoplasm and small central nuclei, floating in a pale blue myxoid background and separated by thin fibrous septa

Why not the others

Remember
Midline, notochord, bubbly cells. Sacrum and clivus are the two ends of the same embryological line.

Go deeper

Treatment is wide en bloc resection, which is difficult in the sacrum and often costs bladder, bowel and sexual function; sacrifice of S3 and below is usually tolerated.

It is relatively radioresistant, so proton beam therapy is used where available.

Local recurrence is the rule if the margin is breached, and late metastases to lung and bone occur.

Apley & Solomon's System of Orthopaedics and Trauma, 10th ed. (CRC Press, 2018); Robbins, Cotran & Kumar Pathologic Basis of Disease, 11th ed. (Elsevier, 2025).

Practise this properly in RecallabFree account, no card: Full Access until 1 January 2027, then ten questions a day free. Every answer verified, every option explained, a current-edition reference on every question.